Breakthrough in Bacterial Infections Treatment: Research from Amsterdam University Medical Center

Strategic Insights -

A new study from the Amsterdam University Medical Center has presented a promising alternative strategy for treating and preventing bacterial infections. The research, published in Glycobiology, focuses on the use of passive immunization with monoclonal antibodies (mAbs) to combat bacterial pathogens such as Staphylococcus aureus and Streptococcus pyogenes. The study's experimental pipeline has successfully identified and generated human mAbs that recognize unique epitopes on the surface glycans of these bacterial priority pathogens.

Key Takeaways:

  • The research highlights the urgent need for alternative strategies to treat and prevent bacterial infections, given the ongoing evolution of antibiotic-resistant pathogens and limited new antibiotic discoveries.
  • The study presents a novel method for generating human mAbs from healthy donor B cells using synthetic mimics of complex bacterial glycans.
  • The experimental pipeline identified functional mAbs recognizing discrete and unique epitopes on the surface glycans of Staphylococcus aureus and Streptococcus pyogenes.
  • The use of chemically-defined synthetic glycans was critical for the discovery and systematic characterization of mAbs.
  • The pipeline can be adapted to different glycan targets, donor material, or specific antibody isotypes.
  • The research concludes that this work paves the way for the discovery of glycan-specific mAbs with clinical relevance to treat, prevent, or diagnose infections with S. aureus, S. pyogenes, or other bacterial pathogens.
  • The study's findings have been peer-reviewed and published in the journal Glycobiology.
  • Researchers Mathieu Claireaux, A. Robin Temming, Gius Kerster, Silvie E. Groenewege, Thijs Voskuilen, Zhen Wang, Jeroen D. C. Codee, Marit J. Gils, and Nina M. Sorge were involved in the study.

Statistics:

  • The ongoing evolution of antibiotic-resistant pathogens affects both human and veterinary health.
  • The study identified functional mAbs recognizing discrete and unique epitopes on the surface glycans of Staphylococcus aureus and Streptococcus pyogenes.
  • The experimental pipeline generated human mAbs from healthy donor B cells using synthetic mimics of complex bacterial glycans.
  • 2 bacterial priority pathogens were targeted in the study: Staphylococcus aureus and Streptococcus pyogenes.
  • The research published in Glycobiology has been peer-reviewed.

Sources:

  • Platform for identifying Human Glycan-Specific Antibodies Against Bacterial Pathogens using Synthetic Glycan Fragments (Glycobiology, 2025)
  • NewsRx. Findings in the Area of Bacterial Infections and Mycoses Reported from Amsterdam University Medical Center (Life Science Weekly, October 21, 2025; p 1448)